California 2017-2018 Regular Session

California Senate Bill SB554

Introduced
2/16/17  
Refer
3/2/17  
Refer
3/27/17  
Refer
4/17/17  
Report Pass
4/25/17  
Engrossed
5/1/17  
Refer
5/26/17  
Refer
6/14/17  
Report Pass
6/20/17  
Refer
6/20/17  
Enrolled
8/24/17  
Chaptered
9/11/17  

Caption

Nurse practitioners: physician assistants: buprenorphine.

Impact

The passage of SB 554 is significant as it aligns California's laws with federal regulations that permit qualified nurse practitioners and physician assistants to manage opioid use more effectively. Specifically, the bill requires at least 24 hours of training on opioid maintenance, detoxification, and related practices. This adjustment is expected to improve patient care in areas heavily impacted by opioid addiction by allowing more healthcare providers to offer treatment options, thereby broadening the reach of substance use services.

Summary

Senate Bill No. 554 seeks to expand the scope of practice for nurse practitioners and physician assistants concerning the dispensing of buprenorphine, which is a medication used in the treatment of opioid use disorder. By adding Sections 2836.4 and 3502.1.5 to the Business and Professions Code, the bill clarifies that state law must not be interpreted to prevent these healthcare providers from furnishing or ordering buprenorphine as long as they comply with specific training requirements outlined in the Comprehensive Addiction Recovery Act of 2016. This enhances access to important medical services for patients dealing with opioid dependency.

Sentiment

The sentiment surrounding SB 554 appears to be generally positive, particularly among proponents who argue it will enhance treatment availability for individuals struggling with addiction. Supporters believe that enabling nurse practitioners and physician assistants to dispense buprenorphine could significantly impact public health by addressing the opioid crisis. However, there are concerns regarding the adequacy of training and supervision of these providers, which could influence the effectiveness of treatment over time.

Contention

Despite its advantages, SB 554 has faced scrutiny regarding the potential risks of expanding prescribing authority without stringent oversight. Some critics argue that while increasing access is crucial, it must not compromise the quality of care or patient safety. The emphasis on training for nurse practitioners and physician assistants, including the necessity for appropriate supervision by a licensed physician, reflects an attempt to balance accessibility with accountability in tackling opioid use disorders.

Companion Bills

No companion bills found.

Similar Bills

CA AB2527

Incarceration: pregnant persons.

CO HB1045

Treatment for Substance Use Disorders

CA AB2487

Physicians and surgeons: continuing education: opiate-dependent patient treatment and management.

HI SB708

Relating To Prescriptive Authority For Clinical Psychologists.

HI SB2489

Relating To Prescriptive Authority For Clinical Psychologists.

CA AB732

County jails: prisons: incarcerated pregnant persons.

CA AB1225

The Dignity for Incarcerated Women Act.